Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed an erratum related to the study on long-acting cabotegravir plus rilpivirine for HIV-1 treatment, which may affect the accuracy of the information presented.
    Difference
    0.1%
    Check dated 2025-05-08T13:20:59.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:54:13.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to include new drug information related to HIV treatment, specifically the addition of Rilpivirine - Injectable Suspension and DTG Tablet, along with the collaborators involved in the study. The previous detailed description of the FLAIR study has been removed, indicating a significant shift in focus.
    Difference
    18%
    Check dated 2025-04-16T14:43:28.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 21, 2025.
    Difference
    0.1%
    Check dated 2025-04-09T09:49:43.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 21, 2025, and version 2.14.2.
    Difference
    0.0%
    Check dated 2025-04-01T23:30:40.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The webpage has updated several location entries, including the addition of new postal codes and the removal of outdated ones, while also changing some formatting in the names of cities and regions. Additionally, the date entries have been revised to reflect new timelines.
    Difference
    2%
    Check dated 2025-03-25T14:03:52.000Z thumbnail image

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.